Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

435
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

523
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
523
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

499
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

623
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
623
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

721
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

469
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning neuroimaging models from health system-scale data.

Nature biomedical engineering·2026
Same author

DWI Positivity in Mild, Nondisabling Acute Cerebral Ischemia: Data From the PRISMS Trial.

Stroke (Hoboken, N.J.)·2026
Same author

Real-world strategies for pulsed field ablation using a variable-loop circular catheter: a compendium of best practices from early adopters.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Stroke Recognition Tools for Spanish-Speaking Consumers: A Nationwide Study.

Stroke·2026
Same author

Incidence and Mortality of Chronic Subdural Hematomas: A Population-Based Study.

Stroke·2025
Same author

Extensive ischemic change on stroke presentation is uncommon: A population-based study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2025

Related Experiment Video

Updated: Apr 17, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.

Mark H Eckman1, Ruth E Wise, Katherine Naylor

  • 1Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati , Cincinnati, OH , USA.

Current Medical Research and Opinion
|February 19, 2015
PubMed
Summary

Developing a decision tool for atrial fibrillation (AF) patients helps integrate personal values into anticoagulant therapy choices, balancing stroke prevention and bleeding risks for shared decision-making.

Keywords:
Atrial fibrillationDecision analysisDecision support toolsShared decision making

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K

Related Experiment Videos

Last Updated: Apr 17, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Decision Science

Background:

  • Patient values are crucial in medical decisions involving quality-of-life tradeoffs, such as anticoagulant therapy in atrial fibrillation (AF).
  • Balancing stroke prevention against hemorrhage risk is a key challenge in AF management.

Purpose of the Study:

  • To describe the development of the Atrial Fibrillation Guideline Support Tool (AFGuST).
  • To assist in integrating patient preferences into anticoagulant therapy decisions for AF patients.

Main Methods:

  • Utilized CHA2DS2VASc and HAS-BLED scores for stroke and hemorrhage risk assessment.
  • Developed a Markov decision analytic model to integrate patient-specific risks and values.
  • Created patient-tailored booklets and informational videos through iterative focus group feedback.

Main Results:

  • Patient preferences significantly influence optimal antithrombotic therapy choice based on individual stroke and bleeding risks.
  • The AFGuST incorporates patient-specific risks and values for outcomes like bleeding and stroke.
  • Decision support materials were developed iteratively with clinicians and patient focus groups.

Conclusions:

  • The AFGuST demonstrates a proof of concept for patient-centered decision support in AF anticoagulation.
  • It facilitates shared decision-making by incorporating individual risks and values.
  • The tool can enhance guideline-based conversations about anticoagulation management.